Safe by design (SbD) and nanotechnology: a much-discussed topic with a prudence?

Safe-by-Design (SbD) has been put forward as a concept to assure that only safe nanomaterials will reach the market and that safety aspects have already been considered in a very early stage of the innovation process. In practice, several laboratory test have been proposed to screen newly developed...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulumian, Mary, Cassee, Flemming R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381576/
https://www.ncbi.nlm.nih.gov/pubmed/34425830
http://dx.doi.org/10.1186/s12989-021-00423-0
_version_ 1783741397992472576
author Gulumian, Mary
Cassee, Flemming R.
author_facet Gulumian, Mary
Cassee, Flemming R.
author_sort Gulumian, Mary
collection PubMed
description Safe-by-Design (SbD) has been put forward as a concept to assure that only safe nanomaterials will reach the market and that safety aspects have already been considered in a very early stage of the innovation process. In practice, several laboratory test have been proposed to screen newly developed nanomaterials and nano-enabled products to assess their hazardous nature. These tests need to have sufficient predictive power for possible adverse effects on human health, not only due to acute (peak) exposures, but also for long-term (low dose) exposures as these materials may accumulate over time in organs and tissues.
format Online
Article
Text
id pubmed-8381576
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83815762021-08-23 Safe by design (SbD) and nanotechnology: a much-discussed topic with a prudence? Gulumian, Mary Cassee, Flemming R. Part Fibre Toxicol Editorial Safe-by-Design (SbD) has been put forward as a concept to assure that only safe nanomaterials will reach the market and that safety aspects have already been considered in a very early stage of the innovation process. In practice, several laboratory test have been proposed to screen newly developed nanomaterials and nano-enabled products to assess their hazardous nature. These tests need to have sufficient predictive power for possible adverse effects on human health, not only due to acute (peak) exposures, but also for long-term (low dose) exposures as these materials may accumulate over time in organs and tissues. BioMed Central 2021-08-23 /pmc/articles/PMC8381576/ /pubmed/34425830 http://dx.doi.org/10.1186/s12989-021-00423-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Editorial
Gulumian, Mary
Cassee, Flemming R.
Safe by design (SbD) and nanotechnology: a much-discussed topic with a prudence?
title Safe by design (SbD) and nanotechnology: a much-discussed topic with a prudence?
title_full Safe by design (SbD) and nanotechnology: a much-discussed topic with a prudence?
title_fullStr Safe by design (SbD) and nanotechnology: a much-discussed topic with a prudence?
title_full_unstemmed Safe by design (SbD) and nanotechnology: a much-discussed topic with a prudence?
title_short Safe by design (SbD) and nanotechnology: a much-discussed topic with a prudence?
title_sort safe by design (sbd) and nanotechnology: a much-discussed topic with a prudence?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381576/
https://www.ncbi.nlm.nih.gov/pubmed/34425830
http://dx.doi.org/10.1186/s12989-021-00423-0
work_keys_str_mv AT gulumianmary safebydesignsbdandnanotechnologyamuchdiscussedtopicwithaprudence
AT casseeflemmingr safebydesignsbdandnanotechnologyamuchdiscussedtopicwithaprudence

Ejemplares similares